In Article 22 of Delegated Regulation (EU) 2016/161, the following paragraph is added:
‘By way of derogation from point (a), from 1 January 2021 to 31 December 2021 the obligation to decommission the unique identifier of medicinal products which the wholesaler intends to distribute outside of the Union shall not apply to products which he intends to distribute in the United Kingdom ( *1 ) .